Quthero is a biotech start-up specializing in regenerative therapies powered by its Q-peptide technology. Q-peptide is a synthetic peptide sequence derived from Angiopoietin-1 that polarizes macrophages away from an inflammatory state and towards a regenerative state. This platform technology addresses critical needs in areas requiring cell survival, anti-inflammatory effects, vascularization, and regenerative support, including post-dermatological procedure healing, wound healing, and cardiovascular health. Dermatological products with Q-peptide are commercial ready and our Q-peptide cardiac drug has been validated in preclinical models, with plans to prepare an IND application pending large animal studies.